CN1C2(c3ccccc3)c3c(-c4ccccc4)sc(-c4ccccc4)c3C1(c1ccccc1)C1C(=O)N(c3ccccc3)C(=O)C12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?